Hamular bursitis as a cause of orofacial pain. A case report.
Journal
Journal of clinical and experimental dentistry
ISSN: 1989-5488
Titre abrégé: J Clin Exp Dent
Pays: Spain
ID NLM: 101603132
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
03
05
2023
accepted:
04
06
2023
medline:
31
7
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
epublish
Résumé
Pterygoid hamular bursitis is an infrequent cause of orofacial pain due to a hypertrophic pterygoid hamulus. The pain is often referred to the pharynx, temporomandibular region and facial zone, and requires a differential diagnosis with other craniofacial entities. This paper describes a patient with pterygoid hamular bursitis that presented pain of neuropathic characteristics in the left retromolar region, associated with odynophagia and temporomandibular joint disorders. Based on the clinical and radiological findings, a surgical resection of the pterygoid hamulus was decided. After the surgical procedure the patient still reported symptoms so additional specific treatments such as peripheral nerve block and infiltration were performed. Four months later, the patient developed a squamous cell carcinoma on the left margin of the tongue, which was surgically treated. At present (thirty months follow-up), the patient has no pain or signs of tumor relapse.
Identifiants
pubmed: 37519325
doi: 10.4317/jced.60702
pii: 60702
pmc: PMC10382159
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e599-e604Informations de copyright
Copyright: © 2023 Medicina Oral S.L.
Déclaration de conflit d'intérêts
Conflicts of interest The authors have no direct financial or other interests in the products or information mentioned in this paper. Blanca Prats-Sisquella, Nikol A. Peeva, Adrià Jorba-García, Tomas Escuin, Javier Bara-Casaus declare no conflicts of interest. Dr. Rui Figueiredo reports grants, personal fees, and non-financial sup- port from MozoGrau (Valladolid, Spain) and from Avinent (Santpedor, Spain) and personal fees from BioHorizons Iberica (Madrid, Spain), Inibsa Dental (Lliçà de Vall, Spain), Dentsply implants Iberia (Barcelona, Spain), and ADIN Implants (Afula, Israel) outside the submitted work. Dr. Figueiredo has also participated as a principal investigator in a randomized clinical trial sponsored by Mundipharma (Cambridge, UK) and in another clinical trial as a sub-investigator for Menarini Richerche (Florence, Italy).
Références
Oral Surg Oral Med Oral Pathol. 1991 Apr;71(4):420-2
pubmed: 2052325
Anesth Pain Med. 2012 Spring;1(4):257-61
pubmed: 24904811
Cranio. 1996 Oct;14(4):306-11
pubmed: 9110625
Anesth Pain Med. 2017 Apr 22;7(3):e44732
pubmed: 28856112
Med Oral Patol Oral Cir Bucal. 2006 Jul 01;11(4):E329-33
pubmed: 16816817
Ann Anat. 1999 Jan;181(1):85-8
pubmed: 10081567
Oral Dis. 2001 Mar;7(2):131-3
pubmed: 11355439
Med Oral Patol Oral Cir Bucal. 2018 Mar 1;23(2):e151-e160
pubmed: 29476673
J Prosthet Dent. 1996 Feb;75(2):205-10
pubmed: 8667281
J Oral Facial Pain Headache. 2014 Winter;28(1):6-27
pubmed: 24482784
Oral Surg Oral Med Oral Pathol. 1989 Aug;68(2):154-7
pubmed: 2780016
Cranio. 1996 Jul;14(3):186-9
pubmed: 9110609
Int J Cancer. 2019 May 15;144(10):2390-2400
pubmed: 30484859
J Craniofac Surg. 2019 Oct;30(7):e643-e645
pubmed: 31233003